Lizhi Inc. (LIZI) stock lost 6.75% at $2.35 in the aftermarket at a volume of 358.32 thousand on November 29. During market hours, the stock saw an increase of 4.56% to close on $2.52 at a volume of 1.55 million. The day’s range of the stock varied between a high of $2.71 and a low …
Lizhi Inc. (LIZI) Plummets in the After Hours Following Q3 Earnings Report Read More »
The best cryptocurrencies are the King (Bitcoin) and the Queen (Ethereum). Other coins are only following suit of the King and the Queen. But some coins want to break the barrier set by the royalty and establish their own through the market. Kadena (KDA) is an example of this. KDA is a hybrid blockchain; it …
What do you need to know about Kadena (KDA) Coin Read More »
Avenue Therapeutics, Inc. (ATXI), a specialty pharmaceutical company, has declined 5.29% in aftermarket trading session. Consequently, ATXI stock is trading at $1.61 at the time of the writing. The decline could be attributed to the profit-taking factor after the stock soared 53.15% during the regular trading session on Monday and closed the day at $1.70. The …
Here You Would Find Why Avenue Therapeutics, Inc. (ATXI) Stock is on a Continuous Rally Read More »
Palatin Technologies Inc. (PTN) stock lost 6.30% in the aftermarket, at $0.8011 against its last close at $0.8550 on November 29. In the previous trading session, the stock saw a good gain of 53.34% at a volume of 164.05 million shares. The day’s volume was as much as 2,770% of the 65-day average of 5.92 …
Palatin Technologies Inc. (PTN) stock falls under Market Corrections in the After hours Read More »
Cumberland Pharmaceuticals Inc. (CPIX) went up by a staggering 115.91% in the aftermarket, at $4.75 on November 29. The after-hours saw a very active volume of 18.44 million, almost the same as the normal trading session on Monday. In the previous market session, the stock lost 0.90%, at the closing value of $2.20, with 18.46 …
New FDA Approval: Cumberland Pharmaceuticals Inc. (CPIX) Surges in the After hours Read More »
Applied DNA Sciences Inc. (APDN) stock fell by 4.46% in the aftermarket, at $5.79 against its last close at $6.06 on November 29. The stock gained 14.34% in the previous trading session at 1.23 million shares exchanging hands. The day’s volume was 1,708% of the 65-day average of 599.3 thousand shares. Intraday trading the stock …
Applied DNA Sciences Inc. (APDN) Falls Down in the After market. Here’s why? Read More »
Lucira Health, Inc. (LHDX) experienced an incline of 3.30% in the premarket following the news that Lucira at-home Test Kits can detect Omicron. However, the last trading session concluded at $6.98 with an incline of 15.56%. LHDX All-In-One Test Kits – Is it the truth? LHDX announced on 29th November 2021 that Lucira Test Kits …
Lucira Health, Inc. (LHDX) stock is surging in premarket – What’s driving it higher? Read More »
Reserve Rights had peaked during the high of the 2021 bull run in April. The cryptocurrency has been largely bearish ever since. RSR token has displayed brief volatile upwards shifts although the bullish momentum had not been able to sustain. At the time of writing, the cryptocurrency stands at a price level of $0.045. The …
Adagio Therapeutics, Inc. (ADGI) experiences an amazing incline of 31.41% in the premarket. However, the last trading session closed at $25.12 with an increase of 34.12%. Omicron SARS-CoV-2 variant – What’s up? On 29th November 2021, ADGI gave details on the ability of its leading SARS-CoV-2 antibody, ADG20. This will help combat the Omicron SARS-CoV-2 …
Adagio Therapeutics, Inc. (ADGI) stock is climbing high – What are the new updates? Read More »
Viemed Healthcare, Inc. (VMD) saw a push of 5.16% in the premarket. However, the last trading session closed at $5.23 with a decrease of 3.15%. Third Quarter 2021 Results by VMD– How was the quarter? VMD announced third quarter 2021 results on 1st November 2021. According to the report, total net revenues came out to …
Viemed Healthcare, Inc. (VMD) stock has seen an incline of 5.16% – Learn why? Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.